Integrative Health and Wellbeing Thrives at New York-Presbyterian
May 31st 2018Individualized holistic, evidence-based medicine will be accessible to more patients in New York beginning in June 2018, when the 2-year-old Integrative Health and Wellbeing program expands from its original site.
Read More
Increased HCV Observed in Adults Who Had Pediatric Heart Surgery
April 10th 2018A higher prevalence of HCV in adults who received surgery for congenital heart disease as children is a "double whammy" when procedures leaves systemic venous congestion affecting hepatic veins, researchers said.
Read More
Despite Guidelines, Shorter HCV Treatment Proven Effective for Black Patients
April 9th 2018Eight weeks of ledipasvir and sofosbuvir for HCV genotype 1 was found as effective as 12 weeks in patients of different race and ethnicity despite guidelines recommending the shorter treatment for non-black patients.
Read More
Inventing OFF After Pushing ON: Progressing Toward Reversing Factor Xa Inhibitor Anticoagulants
March 21st 2018Although the factor Xa (FXa) inhibitor oral anticoagulants have fewer drug interactions and are without burdens associated with warfarin, such as blood test monitoring, dosage adjustment, and diet restriction, they also lack an approved antidote to their anticoagulant effect.
Read More